Arthur S. Kirsch Buys 1,000 Shares of Liquidia Technologies Inc (LQDA) Stock
Liquidia Technologies Inc (NASDAQ:LQDA) Director Arthur S. Kirsch acquired 1,000 shares of the stock in a transaction on Thursday, November 8th. The stock was bought at an average price of $18.25 per share, for a total transaction of $18,250.00. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.
Shares of NASDAQ:LQDA traded down $1.35 during midday trading on Thursday, reaching $20.80. 237 shares of the company’s stock traded hands, compared to its average volume of 67,319. Liquidia Technologies Inc has a 1 year low of $10.52 and a 1 year high of $38.46. The company has a current ratio of 6.27, a quick ratio of 6.27 and a debt-to-equity ratio of 0.40.
Liquidia Technologies (NASDAQ:LQDA) last announced its earnings results on Wednesday, October 31st. The company reported ($0.83) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.26). The firm had revenue of $0.17 million during the quarter, compared to analysts’ expectations of $1.03 million. Research analysts predict that Liquidia Technologies Inc will post -5.67 EPS for the current year.
Several equities research analysts have commented on the company. Cowen assumed coverage on Liquidia Technologies in a research report on Monday, August 20th. They issued an “outperform” rating and a $40.00 price objective on the stock. Needham & Company LLC assumed coverage on Liquidia Technologies in a research report on Monday, August 20th. They issued a “buy” rating and a $30.00 price objective on the stock. Wedbush upped their price objective on Liquidia Technologies from $26.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, November 1st. Zacks Investment Research lowered Liquidia Technologies from a “hold” rating to a “sell” rating in a research report on Tuesday. Finally, Jefferies Financial Group assumed coverage on Liquidia Technologies in a research report on Thursday, November 8th. They issued a “buy” rating and a $27.00 price objective on the stock. One investment analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $31.75.
About Liquidia Technologies
Liquidia Technologies, Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies.
Further Reading: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.